These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31490712)

  • 1. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
    Andaluz A; DeMoss D; Claassen C; Blair S; Hsu J; Bakre S; Khan M; Atem F; Rush AJ
    Am J Drug Alcohol Abuse; 2020; 46(1):49-57. PubMed ID: 31490712
    [No Abstract]   [Full Text] [Related]  

  • 2. Eliminating the benzos: A benzodiazepine-sparing approach to preventing and treating alcohol withdrawal syndrome.
    McCullough MA; Miller PR; Martin T; Rebo KA; Stettler GR; Martin RS; Cantley M; Shilling EH; Hoth JJ; Nunn AM
    J Trauma Acute Care Surg; 2024 Mar; 96(3):394-399. PubMed ID: 37934662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Gabapentin for Alcohol Withdrawal Syndrome in the Hospital Setting: A Randomized Open-Label Controlled Trial.
    DeFoster RE; Morgan RJ; Leung JG; Schenzel H; Vijapura P; Kashiwagi DT; Fischer KM; Philbrick KL; Kung S
    Subst Use Misuse; 2023; 58(13):1643-1650. PubMed ID: 37469099
    [No Abstract]   [Full Text] [Related]  

  • 4. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis.
    Levine AR; Carrasquillo L; Mueller J; Nounou MI; Naut ER; Ibrahim D
    Pharmacotherapy; 2019 Sep; 39(9):881-888. PubMed ID: 31278761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of a gabapentin high dose taper compared to lorazepam in acute inpatient alcohol withdrawal.
    Morrison M; Udeh E; Burak M
    Am J Drug Alcohol Abuse; 2019; 45(4):385-391. PubMed ID: 30990361
    [No Abstract]   [Full Text] [Related]  

  • 6. A Symptom-Triggered Benzodiazepine Protocol Utilizing SAS and CIWA-Ar Scoring for the Treatment of Alcohol Withdrawal Syndrome in the Critically Ill.
    Sen S; Grgurich P; Tulolo A; Smith-Freedman A; Lei Y; Gray A; Dargin J
    Ann Pharmacother; 2017 Feb; 51(2):101-110. PubMed ID: 27733668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.
    Myrick H; Malcolm R; Randall PK; Boyle E; Anton RF; Becker HC; Randall CL
    Alcohol Clin Exp Res; 2009 Sep; 33(9):1582-8. PubMed ID: 19485969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenobarbital and symptom-triggered lorazepam versus lorazepam alone for severe alcohol withdrawal in the intensive care unit.
    Nguyen TA; Lam SW
    Alcohol; 2020 Feb; 82():23-27. PubMed ID: 31326601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
    Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
    J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin to treat acute alcohol withdrawal in hospitalized patients: A systematic review and meta-analysis.
    Mattle AG; McGrath P; Sanu A; Kunadharaju R; Kersten B; Zammit K; Mammen MJ
    Drug Alcohol Depend; 2022 Dec; 241():109671. PubMed ID: 36402053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
    Malcolm R; Myrick LH; Veatch LM; Boyle E; Randall PK
    J Clin Sleep Med; 2007 Feb; 3(1):24-32. PubMed ID: 17557449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of fixed tapering dose regimen versus symptom-triggered regimen of lorazepam for alcohol detoxification.
    Sachdeva A; Chandra M; Deshpande SN
    Alcohol Alcohol; 2014; 49(3):287-91. PubMed ID: 24407777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, open-label, standard controlled, parallel group study of efficacy and safety of baclofen, and chlordiazepoxide in uncomplicated alcohol withdrawal syndrome.
    Girish K; Vikram Reddy K; Pandit LV; Pundarikaksha HP; Vijendra R; Vasundara K; Manjunatha R; Nagraj M; Shruthi R
    Biomed J; 2016 Feb; 39(1):72-80. PubMed ID: 27105601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
    Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
    Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose phenobarbital in addition to symptom-triggered lorazepam in alcohol withdrawal.
    Ibarra F
    Am J Emerg Med; 2020 Feb; 38(2):178-181. PubMed ID: 30744913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Injectable Diazepam and Lorazepam in the Goal-Directed Management of Severe Alcohol Withdrawal.
    Brickel KH; Hodge EK; Zavgorodnyaya D; Schroeder JM; Brown LH; Daley MJ
    Ann Pharmacother; 2024 May; 58(5):453-460. PubMed ID: 37606361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial.
    Martinotti G; di Nicola M; Frustaci A; Romanelli R; Tedeschi D; Guglielmo R; Guerriero L; Bruschi A; De Filippis R; Pozzi G; Di Giannantonio M; Bria P; Janiri L
    Addiction; 2010 Feb; 105(2):288-99. PubMed ID: 20078487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol - Revised: A systematic review-based meta-analysis.
    Pribék IK; Kovács I; Kádár BK; Kovács CS; Richman MJ; Janka Z; Andó B; Lázár BA
    Drug Alcohol Depend; 2021 Mar; 220():108536. PubMed ID: 33503582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.